$3.08
Value $238M
ALTO and NEM stock compared: price, dividend, valuation and results, from SEC filings.
$3.08
Value $238M
$100.05
Value $109B
Alto Ingredients (ALTO) has a market value of $238M and Newmont (NEM) $109B. Over the last year, with dividends, ALTO moved +51.0% and NEM +16.6%. The P/E is 4.8 for ALTO and 11.8 for NEM. Dividend yield: ALTO none, NEM 1.03%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ALTO$238M
NEM$109B
NEM is 457 times ALTO
Revenue, 12 months
ALTO$960M
NEM$26.6B
NEM is 28 times ALTO
Net income, 12 months
ALTO$51M
NEM$9.2B
NEM is 182 times ALTO
Operating margin
ALTO2.7%
NEM–
ROIC
ALTO6.0%
NEM22.0%
16.0 points apart
P/E
ALTO4.8
NEM11.8
NEM is 2.4 times ALTO
Dividend yield
ALTO0.0%
NEM1.0%
1.0 points apart
5-year return
ALTO-41.6%
NEM+100.6%
142.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ALTO-41.6%
NEM+100.6%
| Period | ALTOWith dividends | NEMWith dividends |
|---|---|---|
| 1 year since November 18, 2025 | +51.0%Price +51.0% | +16.6%Price +15.5% |
| 3 years since November 17, 2023 | +31.1%+9.4% a yearPrice +31.1% | +191.5%+42.9% a yearPrice +175.2% |
| 5 years since November 18, 2021 | -41.6%-10.2% a yearPrice -41.6% | +100.6%+14.9% a yearPrice +75.0% |
| 10 years since November 21, 2016 | -59.7%-8.7% a yearPrice -59.7% | +287.0%+14.5% a yearPrice +202.5% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
ALTOAlto IngredientsNEMNewmont
| Price | $3.08 | $100.05 |
|---|---|---|
| Market value | $238M | $109B |
| Enterprise value (EV) | $269M | $105B |
| P/E | 4.8 | 11.8 |
| P/E, 5-year median | – | 15.6 |
| P/B | 0.9 | 3.1 |
| EV/EBIT | 10.5 | 7.5 |
| Free cash flow yield | 15.7% | 9.3% |
| Revenue, 12 months | $960M | $26.6B |
|---|---|---|
| Net income, 12 months | $51M | $9.2B |
| Free cash flow, 12 months | $37M | $10.1B |
| Earnings per share, 12 months | $0.65 | $8.60 |
| Revenue growth, year on year | -4.9% | 21.3% |
| Revenue growth a year, past | +0.5%over 5 years | +14.5%over 5 years |
| EPS growth a year, past | – | +12.7%over 5 years |
| Gross margin | 5.8% | 69.2% |
|---|---|---|
| Operating margin | 2.7% | – |
| Net margin | 5.3% | 34.7% |
| ROIC | 6.0% | 22.0% |
| ROE | 20.3% | 26.7% |
| Cash | $24M | $8.8B |
|---|---|---|
| Total debt | $76M | $5.1B |
| Net debt / EBITDA | 0.6 | -0.2 |
| Interest cover | 3.2× | – |
| Dividend yield | – | 1.0% |
|---|---|---|
| Dividend per share, 12 months | – | $1.03 |
| Dividend growth a year, past | – | – |
| Buyback yield | – | 2.1% |
| Shareholder yield | – | 3.2% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Newmont ($109B) is about 457.2 times Alto Ingredients ($238M), at today's prices.
Since November 21, 2016, ALTO's price moved -59.7% and NEM's +202.5%. With dividends: ALTO -59.7% (-8.7% a year), NEM +287.0% (+14.5% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Alto Ingredients and 1.03% for Newmont. Over the last twelve months they paid – and $1.03 per share.
At today's price, the P/E is 4.8 for ALTO and 11.8 for NEM. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 5.3% for Alto Ingredients and 34.7% for Newmont, and the operating margin 2.7% and –. Revenue was $960M and $26.6B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.